Xiromed Company Profile
✉ Email this page to a colleague
What is the competitive landscape for XIROMED, and what generic and branded alternatives to XIROMED drugs are available?
XIROMED has seventy-two approved drugs.
Drugs and US Patents for Xiromed
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Xiromed | OMEPRAZOLE | omeprazole | CAPSULE, DELAYED REL PELLETS;ORAL | 212977-001 | Dec 10, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Xiromed | ACYCLOVIR | acyclovir | OINTMENT;TOPICAL | 201501-001 | Jan 29, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Xiromed | ESTARYLLA | ethinyl estradiol; norgestimate | TABLET;ORAL-28 | 090794-001 | Jan 30, 2013 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Xiromed | DROSPIRENONE AND ETHINYL ESTRADIOL | drospirenone; ethinyl estradiol | TABLET;ORAL-28 | 202131-001 | May 4, 2015 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Xiromed | INTROVALE | ethinyl estradiol; levonorgestrel | TABLET;ORAL | 079064-001 | Sep 27, 2010 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Xiromed | NAFTIFINE HYDROCHLORIDE | naftifine hydrochloride | CREAM;TOPICAL | 210038-001 | Sep 22, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Xiromed | PROGESTERONE | progesterone | CAPSULE;ORAL | 205229-001 | Oct 20, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for XIROMED drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
Similar Applicant Names
Here is a list of applicants with similar names.